SB-0189, As Passed Senate, May 12, 2005
SUBSTITUTE FOR
SENATE BILL NO. 189
A bill to amend 1978 PA 368, entitled
"Public health code,"
(MCL 333.1101 to 333.25211) by adding section 17766b.
THE PEOPLE OF THE STATE OF MICHIGAN ENACT:
Sec. 17766b. (1) Except as otherwise provided under this
section, a person who possesses ephedrine or pseudoephedrine for
retail sale pursuant to a license issued under the general sales
tax act, 1933 PA 167, MCL 205.51 to 205.78, shall maintain all
products that contain any compound, mixture, or preparation
containing any detectable quantity of ephedrine or pseudoephedrine,
a salt or optical isomer of ephedrine or pseudoephedrine, or a salt
of an optical isomer of ephedrine or pseudoephedrine behind a
counter where the public is not permitted, within a locked case so
that a customer wanting access to the product must ask a store
employee for assistance, or within 20 feet of a counter that allows
the attendant to view the products in an unobstructed manner or
utilize an antitheft device on those products that uses special
package tags and detection alarms designed to prevent theft along
with constant video surveillance as follows:
(a) The video camera is positioned so that individuals
examining or removing those products are visible.
(b) The video camera is programmed to record, at a minimum, a
1-second image every 10 seconds.
(c) The video images must be maintained for a minimum of 6
months and made available to any law enforcement agency upon
request.
(d) The retailer shall prominently display a sign indicating
that the area is under constant video surveillance in a conspicuous
location, clearly visible to the public.
(2) If the products described under subsection (1) are
maintained within 20 feet of a counter and that counter is not
staffed by 1 or more employees at all times, then the retail
distributor shall utilize antitheft devices and video surveillance
as provided under subsection (1) when the counter is not staffed.
If all of the products described under subsection (1) are
maintained behind the counter or within a locked case, then the
retailer is not required to maintain a log or any other type of
record detailing the sale of those products.
(3) A person who sells a product described in subsection (1)
shall do each of the following:
(a) Require the purchaser of a product described under
subsection (1) to produce a valid photo identification that
includes the individual's name and date of birth.
(b) Except as otherwise provided under subsection (2),
maintain a log or some type of record detailing the sale of a
product described under subsection (1), including the date of the
sale, the name and date of birth of the buyer, and the amount and
description of the product sold. The log or other means of
recording the sale as required under this subdivision shall be
maintained for a minimum of 6 months and made available to <<only a>> law
enforcement agency upon request. <<The log or other means of recording
the sale is not a public record and is not subject to the freedom of information act, 1976 PA 442, MCL 15.231 to 15.246. A person shall not sell or provide a copy of the log or other means of recording the sale to another for the purpose of surveys, marketing, or solicitations.>>
(4) A person shall not knowingly do any of the following:
(a) Sell any product described under subsection (1) to an
individual under 18 years of age.
(b) Sell in a single over-the-counter sale more than 2
packages, or 48 tablets or capsules, of any product described under
subsection (1) to any individual.
(c) Sell in a single over-the-counter sale more than 2
personal convenience packages containing 2 tablets or capsules each
of any product described under subsection (1) to any individual.
(5) This section does not apply to the following:
(a) A pediatric product primarily intended for administration
to children under 12 years of age according to label instructions.
(b) A product containing pseudoephedrine that is in a liquid
form if pseudoephedrine is not the only active ingredient.
(c) A product that the state board of pharmacy, upon
application of a manufacturer or certification by the United States
drug enforcement administration as inconvertible, exempts from this
section because the product has been formulated in such a way as to
effectively prevent the conversion of the active ingredient into
methamphetamine.
(d) A product that is dispensed pursuant to a prescription.
(6) A person who violates this section is responsible for a
state civil infraction as provided under chapter 88 of the revised
judicature act of 1961, 1961 PA 236, MCL 600.8801 to 600.8835, and
may be ordered to pay a civil fine of not more than $50.00 for each
violation.
(7) A person described under subsection (1) shall post, in a
place close to the point of sale and conspicuous to both employees
and customers, a sign produced by the department of community
health that includes the following statement:
"The sale of any product that contains any compound, mixture,
or preparation containing any detectable quantity of ephedrine or
pseudoephedrine, a salt or optical isomer of ephedrine or
pseudoephedrine, or a salt of an optical isomer of ephedrine or
pseudoephedrine to a minor under 18 years of age is prohibited by
law.".
(8) If the sign required under subsection (7) is more than 6
feet from the point of sale, it shall be 5-1/2 inches by 8-1/2
inches and the statement required under subsection (7) shall be
printed in 36-point boldfaced type. If the sign required under
subsection (7) is 6 feet or less from the point of sale, it shall
be 2 inches by 4 inches and the statement required under subsection
(7) shall be printed in 20-point boldfaced type.
(9) The department of community health shall produce the sign
required under subsection (7) and make copies of the sign available
for distribution to licensed retailers described in subsection (1)
free of charge on the effective date of this section. Licensed
retailers described in subsection (1) shall obtain copies of the
sign from the department of community health and distribute them
free of charge, upon request, to persons who are subject to
subsection (7).
(10) It is an affirmative defense to a charge pursuant to
subsection (4)(a) that the defendant had in force at the time of
the citation and continues to have in force a written policy for
employees to prevent the sale of products that contain any
compound, mixture, or preparation containing any detectable
quantity of ephedrine or pseudoephedrine, a salt or optical isomer
of ephedrine or pseudoephedrine, or a salt of an optical isomer of
ephedrine or pseudoephedrine to persons under 18 years of age and
that the defendant enforced and continues to enforce the policy. A
defendant who proposes to offer evidence of the affirmative defense
described in this subsection shall file and serve notice of the
defense, in writing, upon the court and the prosecuting attorney.
The notice shall be served not less than 14 days before the hearing
date.
(11) A prosecuting attorney who proposes to offer testimony to
rebut the affirmative defense described in subsection (10) shall
file and serve a notice of rebuttal, in writing, upon the court and
the defendant. The notice shall be served not less than 7 days
before the hearing date and shall contain the name and address of
each rebuttal witness.
(12) One year after the effective date of the amendatory act
that added this section, the department of state police shall
submit a written report to the legislature regarding the impact and
effectiveness of the amendatory act that added this section,
including, but not limited to, the number of clandestine
methamphetamine lab incidents before and after this legislation.
(13) Notwithstanding any other provision of law, beginning on
the effective date of the amendatory act that added this section, a
city, township, village, county, other local unit of government, or
political subdivision of this state shall not impose any new
requirement or prohibition pertaining to the sale of a product
described under subsection (1). This subsection does not
invalidate or otherwise restrict a requirement or prohibition
described in this subsection existing on the effective date of the
amendatory act that added this section.
Enacting section 1. This amendatory act takes effect 6 months
after the date it is enacted.